nach oben

Erschienen in:

19.10.2021 | Neuropathischer Schmerz | Zertifizierte Fortbildung

Schädigung der Nervenfasern

Small-fiber-Neuropathien

verfasst von: Dr. med. Juliane Sachau, Jun.-Prof. Dr. med. Elena Enax-Krumova

Erschienen in: NeuroTransmitter | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Auszug

Patienten mit Small-fiber-Neuropathien leiden häufig unter neuropathischen Schmerzen wie Brennschmerzen und einschießenden Schmerzattacken, aber auch unangenehmen Missempfindungen und Störungen des Temperaturempfindens. Begleitend können autonome Funktionsstörungen durch Schädigung der kleinkalibrigen vegetativen Nervenfasern auftreten und zu Symptomen wie einer orthostatischen Dysregulation, Hypo-/Hyperhidrosis, Obstipation/Diahrrö, Palpitationen oder einer erektilen Dysfunktion führen. Diese Symptome haben oft eine eingeschränkte Lebensqualität zur Folge. …

Terkelsen AJ et al. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol 2017;16(11):934-44

Levine TD. Small Fiber Neuropathy: Disease Classification Beyond Pain and Burning. J Cent Nerv Syst Dis 2018;10:1179573518771703.

Haroutounian S et al. Diagnostic criteria for idiopathic small fiber neuropathy: A systematic review. Muscle Nerve 2021 Feb;63(2):170-7

Itani M et al. Small and large fiber sensory polyneuropathy in type 2 diabetes: Influence of diagnostic criteria on neuropathy subtypes. J Peripher Nerv Syst 2021;26(1):55-65

Devigili G et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain J Neurol 2008;131(Pt 7):1912-25

Tesfaye S et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33(10):2285-93

Schlereth T. Guideline "diagnosis and non interventional therapy of neuropathic pain" of the German Society of Neurology (DGNdeutsche Gesellschaft für Neurologie). Neurol Res Pract 2020;2:16

Backonja MM et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013;154(9):1807-19

Rolke R et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006;123(3):231-43

10.

Magerl W et al. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 2010;151(3):598-605

11.

Pfau DB et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain 2014;155(5):1002-15

12.

Koulouris AE et al. Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic Pain. Pain Med Malden Mass2020;21(10):2336-47

13.

Wasan AD et al. Test-Retest and Inter-Examiner Reliability of a Novel Bedside Quantitative Sensory Testing Battery in Postherpetic Neuralgia Patients. J Pain 2020;21(7-8):858-68

14.

Zhu GC et al. Concurrent validity of a low-cost and time-efficient clinical sensory test battery to evaluate somatosensory dysfunction. Eur J Pain Lond Engl 2019;23(10):1826-38

15.

Reimer M et al. Sensory bedside testing: a simple stratification approach for sensory phenotyping. Pain Rep2020;5(3):e820

16.

Wang L et al. Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res 1990;261(1):25-33

17.

Lauria G et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst JPNS. 2010;15(3):202-7

18.

Provitera V et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol 2016;23(2):333-8

19.

Provitera V et al. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol 2018;25(6):848-53

20.

Lauria G et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010;17(7):903-12, e44-49

21.

Chen X et al. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care 2015;38(6):1138-44

22.

Loavenbruck A et al. Quantification of sweat gland volume and innervation in neuropathy: Correlation with thermoregulatory sweat testing. Muscle Nerve 2014;50(4):528-34

23.

Grayston R et al. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum 2019;48(5):933-40

24.

Evdokimov D et al. Reduction of skin in-nervation is associated with a severe fibromyalgia phenotype. Ann Neurol 2019;86(4):504-16

25.

Üçeyler N. Small fiber pathology - a culprit for many painful disorders? Pain 2016;157Suppl1:60-6

26.

Penza P et al. Painful neuropathy in subclinical hypo-thyroidism: clinical and neuropathological recovery after hormone replacement therapy. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 2009;30(2):149-51

27.

Nodera H et al. Epidermal reinnervation concomitant with symptomatic improvement in a sensory neuropathy. Muscle Nerve 2003;27(4):507-9

28.

Singleton JR et al. Exercise increases cutaneous nerve density in diabetic patients without neuropathy. Ann Clin Transl Neurol 2014;1(10):844-9

29.

Müller LJ, Marfurt CF, Kruse F, Tervo TMT. Corneal nerves: structure, contents and function. Exp Eye Res 2003;76(5):521-42

30.

Cruzat A, Qazi Y, Hamrah P. In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease. Ocul Surf. Januar 2017;15(1):15-47

31.

Perkins BA et al. Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study. Diabetologia 2018;61(8):1856-61

32.

Jiang M-S et al. Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis. Br J Ophthalmol 2016;100(1):9-14

33.

Petropoulos IN et al. Corneal confocal microscopy: ready for prime time. Clin Exp Optom 2020;103(3):265-77

34.

Merkies ISJ, Faber CG, Lauria G. Advances in diagnostics and outcome measures in peripheral neuropathies. Neurosci Lett 2015;596:3-13

35.

Valeriani M et al. Clinical usefulness of laser evoked potentials. Neurophysiol Clin Clin Neurophysiol 2012;42(5):345-53

36.

Siedler G, Sommer C, Üçeyler N. Pain-related evoked potentials in patients with large, mixed, and small fiber neuropathy. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 2020;131(3):635-41

37.

Hüllemann P et al. Cold-evoked potentials versus contact heat-evoked potentials-Methodological considerations and clinical application. Eur J Pain Lond Engl 2019;23(6):1209-20

38.

Weidner C et al. Acute effects of sub-stance P and calcitonin gene-related peptide in human skin--a microdialysis study. J Invest Dermatol 2000;115(6):1015-20

39.

Namer B et al. Axon reflex flare and quantitative sudomotor axon reflex contribute in the diagnosis of small fiber neuropathy. Muscle Nerve 2013;47(3):357-63

40.

Peters MJH et al. Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology 2013;81(15):1356-60

41.

de Greef BTA et al. Associated conditions in small fiber neuropathy - a large cohort study and review of the literature. Eur J Neurol 2018;25(2):348-55

42.

Eijkenboom I et al. Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. J Neurol Neurosurg Psychiatry 2019;90(3):342-52

43.

Freeman R et al. Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology 2020;95(22):1005-14

44.

Dib-Hajj SD et al. Sodium channels in pain disorders: pathophysiology and prospects for treatment. Pain 2017;158 Suppl 1:S97-107

45.

Dohrn MF, Lampert A, Üçeyler N, Kurth I. [Neuropathic pain syndromes and channelopa-thies]. Internist Januar 2019;60(1):90-7.

46.

McDonnell A et al. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile. Brain J Neurol 2016;139(Pt 4):1052-65

47.

Faber CG et al. Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012;71(1):26-39

48.

Faber CG et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A2012;109(47):19444-9

49.

Huang J et al. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy. Brain J Neurol 2014;137(Pt 6):1627-42

50.

Eggermann K Hereditary Neuropathies. Dtsch Arzteblatt Int 2018;115(6):91-7

51.

Persson A-K et al. Sodium Channels, Mito-chondria, and Axonal Degeneration in Peripheral Neuropathy. Trends Mol Med 2016;22(5):377-90

52.

Fischer TZ et al. A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia. Ann Neurol 2009;65(6):733-41

53.

Jo S, Bean BP. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States. Mol Pharmacol 2017;91(4):277-86

54.

Adams D et al. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol 2019;15(7):387-404

55.

Koike H et al. Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology 2016;87(21):2220-9

56.

Barroso FA et al. Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 2017;24(3):194-204

57.

Adams D et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N Engl J Med 2018;379(1):11-21.

58.

Benson MD et al. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. N Engl J Med 2018;379(1):22-31

59.

Üçeyler N, Ganendiran S, Kramer D, Sommer C. Characterization of pain in fabry disease. Clin J Pain. Oktober 2014;30(10):915-20

60.

Biegstraaten M et al. Small fiber neuropathy in Fabry disease. Mol Genet Metab 2012;106(2):135-41

61.

de Greef BTA et al. No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy. PloS One 2016;11(2):e0148316

62.

Schiffmann R et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001;285(21):2743-9

63.

Schiffmann R et al. Enzyme re-placement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 2003;28(6):703-10

64.

Hilz MJ, Brys M, Marthol H, Stemper B, Dütsch M. Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology 2004;62(7):1066-72

65.

Schiffmann R et al. Enzyme replace-ment therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 2006;34(1):53-6

66.

Germain DP et al. Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat. N Engl J Med 2016;375(6):545-55

Titel: Schädigung der Nervenfasern
Small-fiber-Neuropathien
verfasst von: Dr. med. Juliane Sachau
Jun.-Prof. Dr. med. Elena Enax-Krumova
Publikationsdatum: 19.10.2021
Verlag: Springer Medizin
Schlagwörter: Neuropathischer Schmerz
Small-Fiber-Neuropathie
Erschienen in: NeuroTransmitter / Ausgabe 10/2021
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI: https://doi.org/10.1007/s15016-021-9199-1

Neu in den Fachgebieten Neurologie und Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Small-fiber-Neuropathien

Auszug

Neu in den Fachgebieten Neurologie und Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Delir kann Demenz begünstigen

Manche Gestagene können das Risiko für Meningeome erhöhen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2021

Selbstberauschung

Die Pandemie als Chance, die Therapie bei Depressionen zu überdenken

Lernen und Austausch in einer virtuellen Welt

Galcanezumab bei therapierefraktären Patienten mit Migräne rasch und anhaltend wirksam

Ein neues Zeitalter bricht an

Der Strukturwandel gelingt nur mit uns!

Neu in den Fachgebieten Neurologie und Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Delir kann Demenz begünstigen

Manche Gestagene können das Risiko für Meningeome erhöhen